Advances in systemic therapy in pancreatic cancer Review
| Author: | Yu, K. H. |
| Review Title: | Advances in systemic therapy in pancreatic cancer |
| Keywords: | cancer chemotherapy; treatment response; cancer surgery; unclassified drug; overall survival; genetics; review; cancer localization; erlotinib; fluorouracil; placebo; advanced cancer; cancer combination chemotherapy; systemic therapy; drug targeting; gemcitabine; paclitaxel; pancreatic neoplasms; cancer staging; antineoplastic agent; dna repair; ipilimumab; cancer immunotherapy; progression free survival; carcinoma, pancreatic ductal; maintenance therapy; genetic variability; pathology; irinotecan; tumor suppressor gene; immunotherapy; folinic acid; mismatch repair; adjuvant chemotherapy; pancreas tumor; pancreatic adenocarcinoma; oncogene k ras; oxaliplatin; nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase; mlh1 gene; chemoradiotherapy; olaparib; molecularly targeted therapy; atm gene; pancreas metastasis; molecular targeted therapy; pancreatic ductal carcinoma; germline mutation; procedures; msh2 gene; high throughput sequencing; msh6 gene; nivolumab; niraparib; dna damage repair; humans; prognosis; human; pembrolizumab; pms2 gene; irinotecan sucrosofate; chimeric antigen receptor t-cell immunotherapy; sotorasib; adagrasib; asp 3082; autogene cevumeran; kirsten rat sarcoma viral oncogene homolog (kras); poly(adenosine diphosphate-ribose) polymerase (parp) |
| Journal Title: | Hematology/Oncology Clinics of North America |
| Volume: | 38 |
| Issue: | 3 |
| ISSN: | 0889-8588 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-06-01 |
| Start Page: | 617 |
| End Page: | 627 |
| Language: | English |
| DOI: | 10.1016/j.hoc.2024.03.002 |
| PUBMED: | 38575456 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Review -- MSK corresponding author is Kenneth Yu -- Issue titled "Malignancies of the Upper Gastrointestinal Tract" (ISBN: 978-0-443-29596-6) -- Source: Scopus |
